Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy.

about

Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy.

Item

http://www.wikidata.org/entity/Q46098962

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@en

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@nl

type

Item

label

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@en

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@nl

prefLabel

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@en

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@nl

P1476

Complete Response of Para-Aort ...... er Treated to S-1 Monotherapy.

@en

P2093

Nobuhiro Fujita

http://www.w3.org/2001/XMLSchema#string

Norihiko Koide

http://www.w3.org/2001/XMLSchema#string

Tomonori Miyazawa

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.

P304

46-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4021/WJON619W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29147329

http://www.w3.org/2001/XMLSchema#string

P932

5649918

http://www.w3.org/2001/XMLSchema#string